Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394185 · ClinicalTrials.gov registry record · Phase 1
Effects of Dronabinol (Oral THC) on Cannabis Use
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01394185: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT01394185 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01394185, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.
Interventions
- DRUG Placebo
- DRUG Dronabinol 120mg/day
- DRUG Dronabinol 240mg/day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01394185
The ClinicalTrials.gov registry entry for NCT01394185 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01394185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01394185 about?
NCT01394185 is a clinical study titled "Effects of Dronabinol (Oral THC) on Cannabis Use". Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary ...
What is the current status of trial NCT01394185?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2011-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01394185?
The interventions under investigation include: Placebo (DRUG), Dronabinol 120mg/day (DRUG), Dronabinol 240mg/day (DRUG).
Who is sponsoring clinical trial NCT01394185?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.